Organon & Co | OGN - Market Capitalization


Organon & Co reported $2.07B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Celltrion KRW 40.04T 3.19T Sep/2025
Cspc Pharmaceutical CNY 107.03B 26.09B Sep/2025
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Divis Laboratories Ltd INR 1.62T 72.34B Feb/2026
Gilead Sciences USD 183.59B 31.31B Feb/2026
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 580.82M 31.21M Jun/2025
Laboratorios Farma EUR 3.68B 430.05M Jan/2026
Malin Corporation EUR 150.45M 12.13M Jan/2026
Medical Developments International AUD 61.96M 16.34M Jun/2025
Merck USD 300.37B 39.11B Feb/2026
Neuren Pharmaceuticals AUD 1.75B 152.5M Jun/2025
Novartis USD 303.91B 57.84B Feb/2026
Organigram Holdings CAD 191.77M 187.03M Feb/2026
Organon & Co USD 1.89B 29.17M Feb/2026
Ovoca Bio EUR 7.54M 4.28M Jun/2022
Pharma Mar EUR 1.63B 241.7M Sep/2025
Qiagen NV USD 9.46B 440.29M Feb/2026
Sartorius EUR 8.12B 8.29B Feb/2026
Sino Biopharmaceutical CNY 90.06B 33.55B Jun/2025